Volume 29, Issue 5 , Pages 554-561, May 2010
Duration of left ventricular assist device support: Effects on abnormal calcium cycling and functional recovery in the failing human heart
Background
Intracellular Ca2+ handling is abnormal in human heart failure. Studies have demonstrated that left ventricular assist device (LVAD) support reverses phenotypic alterations, suggesting that, in select patients, LVAD support may be a bridge to recovery. Few studies have related support duration to phenotypic recovery. We hypothesized that reversal of impaired sarcoendoplasmic reticulum (SR) Ca2+ cycling following LVAD implantation is duration-dependent.
Methods
We used post-rest potentiation to assess SR function, and Western blot analysis to measure Ca2+-cycling proteins. Left ventricular tissue from 10 non-failing hearts, 8 failing hearts and 10 LVAD-supported hearts was analyzed. Support ranged from 7 to 334 days. The median duration, 115 days, divided patients into short- and long-term support groups.
Results
Post-rest potentiation (PRP) response recovered after short-term LVAD support to a level (116.8 ± 12.1%; n = 5) close to non-failing (123.4 ± 12.0%; n = 10) hearts, but recovery after long-term support (23.5 ± 7.0%; n = 5) remained closer to that of failing hearts (13.5 ± 5.6%). We found a similar pattern of normalization for SR Ca2+-ATPase protein and the phospholamban/SR Ca2+-ATPase ratio (non-failing: 0.66 ± 0.11; failing: 1.21 ± 0.23; short-duration LVAD: 0.68 ± 0.14; long-duration LVAD: 1.67 ± 0.30; correlation p < 0.001; r = 0.93). The ratio also tended to correlate with the PRP response after unloading (p = 0.05; r = −0.65).
Conclusions
SR Ca2+ handling improved during early LVAD support, but long-term support was associated with abnormal Ca2+ cycling. These findings cast doubt on strategies designed to wean patients after complete unloading with an LVAD.
Keywords: heart failure, heart-assist device, contractility, Ca2+, sarcoendoplasmic reticulum Ca2+ ATPase
To access this article, please choose from the options below
Current affiliation for M.L.O: Department of Molecular Physiology and Biophysics, University of Houston, Houston, Texas.
PII: S1053-2498(09)00848-1
doi:10.1016/j.healun.2009.10.015
© 2010 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
Volume 29, Issue 5 , Pages 554-561, May 2010
